We're attending SfN, Washington, DC in November 2023.

Our Transactions

We combine deep, personal industry knowledge and M&A experience in biotechnology to support our clients in developing and executing their M&A strategy.

Ba 5

Our track record

Since 2019, we have completed 70+ biotechnology strategy reviews, undertaken 20+ sell-side transactions & 40+ buy-side projects.

Whilst much of our work in the M&A space is confidential, a selection of our completed projects are listed below.

We support a broad set of transactions, including:

  • Mergers
  • Acquisitions
  • Management-led buyouts
  • Disposals (assets and stock)
  • Specialist Commercial Due Diligence (CDD)

We have a proprietary database of sellers globally, covering manufacturers, distributors and hybrid resellers.

European life science distribution companies Veterinary diagnostics distributors
IVD Reagents and raw materials Life science reagent distributors
Manufactures of antibodies, kits and proteins IVD reagent and raw materials

Recent Transactions

Fortis Abcore

Abcore is Acquired by Fortis Life Sciences

Abcore approached Pivotal Scientific to exclusively manage the sale of the company to Fortis Life Sciences, trusting our previous support and recognizing our skills in M&A…

Read More »

Chromocyte Biocompare2

Chromocyte is Acquired by Biocompare

The Chromocyte Journey from startup to maturity to acquisition: Pivotal Scientific has assisted Chromocyte throughout its business lifecycle. We are delighted to have supported it…

Read More »

Arlington Scientific acquires non-mammalian blocking buffer product line from Clark McDermith

Pivotal Scientific are pleased to announce their involvement in Arlington Scientific, Inc. acquiring the non-mammalian blocking buffer product line from Clark McDermith, former owner of East…

Read More »


Pivotal Scientific advises Atlas Antibodies on its purchase of Evitria

Pivotal Scientific Limited supported Atlas Antibodies in their decision making on the purchase of Evitria by undertaking commercial due diligence and providing expert advisory services. Atlas Antibodies wanted to make…

Read More »

Nordic Scicons

Pivotal Scientific advises Nordic-MUbio on its purchase of SCICONS

Pivotal Scientific Limited (PSL) is pleased to announce its assistance in the sale of Hungarian based Biotechnology company SCICONS to Nordic MUbio based in the…

Read More »

Lsbio Abab

Pivotal Scientific advises Absolute Antibody on its sale to LSBio

Pivotal Scientific are delighted to have advised the shareholders of Absolute Antibody, Ltd. (UK) and its sister company Kerafast on their sale to LSBio (USA)….

Read More »

Clinisciences Antibodybcn

Pivotal Scientific advises Antibody BCN on its sale to CliniSciences

CliniSciences adds to its portfolio of companies Pivotal Scientific Limited (PSL) is pleased to announce its assistance in the sale of Spanish based Biotechnology company AbBcn…

Read More »

Lsbio Everest

LifeSpan BioSciences, Inc. announces the acquisition of Everest Biotech

Release Date: July 31st, 2019 Seattle, Washington State, USA– June 2019 – LifeSpan BioSciences (LSBio), a leading provider of antibodies and life science research reagents…

Read More »

Medix Eastcoast

Pivotal Scientific advises EastCoast Bio on its sale to Medix Biochemica

A successful transaction benefitting both parties. Pivotal Scientific is delighted to announce its assistance in the sale of US-based biotech firm EastCoast Bio to the…

Read More »

19/02/2022 Fortis Life Sciences acquires Abcore Inc Abcore
06/11/2021 Biocompare acquires Chromocyte Chromocyte
25/10/2021 Arlington Scientific acquires non-mammalian buffers from Clark McDermith Clark McDermith
10/08/2021 Thompson Street Capital acquires Vector Labs TSCP
28/07/2021 Atlas Antibodies acquires Evitria Atlas Antibodies
05/04/2021 Scicons acquired by Nordic-MUbio Nordic-MUbio
31/12/2020 Absolute Antibody acquired by TSCP Absolute Antibody
20/10/2020 Dianova acquired by Calibre Scientific Dianova
04/06/2020 AntibodyBCN acquired bu Clinisciences AntibodyBCN
03/06/2020 EastCoastBio acquired by Medix Biochemica EastCoastBio
08/06/2019 LSBio acquires Everest Biotech Everest Biotech
12/02/2019 LSBio acquires Nordic-MUbio and Exalpha Biologicals Nordic-MUbio
01/06/2018 Exalpha Biologicals acquires Gallus Immunetech Exalpha Biologicals
30/04/2018 CalibreScientific acquire Biozol GmbH Biozol
01/03/2018 Biologo acquired by Nordic-MUbio Nordic-MUbio
04/02/2018 Absolute Antibody Merge with Kerafast Absolute Antibody
2017 Exalpha Biologicals acquired by LSM Holdings Exalpha Biologicals
2017 Innova Biosciences acquired by SYNGIS AG Innova Biosciences
2015 Nordic-MUbio acquires Brighter Ideas Inc Nordic-MUbio
2015 Origene Inc acquires Acris Antibodies GmbH Acris Antibodies
2014 Clinisciences acquires Generon Clinisciences
2013 Nordic Immunological Labs acquires MUbio Nordic Immunological Labs
2013 Nordic-MUbio acquires An Der Grub Bio Research GmbH (ADG) Nordic-MUbio